Skip to main content

Opioids and Other Neuropeptides: Functional Interactions with Autonomic Systems

  • Chapter
  • 116 Accesses

Part of the book series: Topics in the Neurosciences ((TNSC,volume 2))

Abstract

The autonomic nervous system functions at a delicate balance to sustain a relatively constant internal milieu despite exposure to ever changing external and internal environments. For example, changes in temperature and altitude evoke compensatory autonomic responses to maintain body temperature and respiratory function. Likewise, sudden standing can lower arterial pressure, resulting in activation of baroreceptor reflex arcs to sustain cardiovascular function. In addition to alterations in the external environment, disease and injury can necessitate compensatory autonomic responses. However, in pathophysiological states, the autonomic nervous system may be severely compromised and unable to function in the rapid restoration of homeostasis.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Krieger, D.T. 1982. Endorphins and enkephalins. Disease-a-Month. Chicago: Year Book Medical Publisher, Inc., 1–53.

    Google Scholar 

  2. Watson, S.J. and Barchas, J.D. 1979. Anatomy of the endogenous opioid peptides and related substances: the enkephalins, beta-endorphin, beta-lipotropin and ACTH. In Beer, R.F. and Bassett, E.G.(eds.): Mechanisms of Pain and Analgesic Compounds. New York, Raven, 227–238.

    Google Scholar 

  3. Hokfelt, T., Elde, R., Johansson, O., Terenius, L. and Stein, L. 1977. The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system. Neurosci. Lett. 5, 25–31.

    Article  PubMed  CAS  Google Scholar 

  4. Puig, M.M., Gascon, P., Craviso, G.L. and Musacchio, J.M. 1977. Endogenous opiate receptor ligand: electrically induced release in the guinea pig ileum. Science 195, 419–420.

    Article  PubMed  CAS  Google Scholar 

  5. Diguilio, A.M., Yang, H.Y.T., Lutold, B., Fratta, W., Hong J. and Costa, E. 1978. Characterization of enkephalin-like material extracted from sympathetic ganglia. Neuropharmacology 17, 989–992.

    Article  Google Scholar 

  6. Schultzburg, M., Hokfelt, T., Lundberg, J., Terenius, L., Elfirm, L.G., and Elde, R. 1978. Enkephalin-like immuno-reactivity in nerve terminals in sympathetic ganglia and adrenal medulla and in adrenal medullary cells. Acta Physiol. Scand 103, 475–477.

    Article  Google Scholar 

  7. Viveros, O.H., Diliberto, E.J., Hazum, E. and Chang, K.J. 1979. Opiate-like materials in the adrenal medulla: evidence for storage and secretion with catecholamines. Mol. Pharm. 16, 1101–1108.

    CAS  Google Scholar 

  8. Guillemin, R., Vargo,T., Rossier, J., Minick, S., Ling, N. Rivier, C, Vale, W. and Bloom, F. 1977. Beta-endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 197, 1367–1369.

    Article  PubMed  CAS  Google Scholar 

  9. Holaday, J.W. and Tortella, F.C. 1984. Multiple opioid receptors: possible physiological functions of mu and delta binding sites in vivo. In Muller, E.E. and Genazzani, A.R. (eds.): Central and Peripheral Endorphins: Basic and Clinical Aspects. New York: Raven, 237–250.

    Google Scholar 

  10. Pfeiffer, A. and Herz, A. 1982. Discrimination of three opiate receptor binding sites with the use of a computerized curve fitting technique. Mol. Pharmacol. 21, 266–271.

    PubMed  CAS  Google Scholar 

  11. Holaday, J.W., Long, J.B. and Tortella, F.C. Evidence for kappa, mu and delta opioid binding site interactions in vivo. Fed. Proc. In press.

    Google Scholar 

  12. Gordon, C.J., Rezvani, A.H. and Heath, J.E. 1984. Role of beta-endorphin in the control of body temperature in the rabbit. Neurosci. Biobehav. Rev. 8, 73–82.

    Article  PubMed  CAS  Google Scholar 

  13. Clark. W.G. 1979. Influence of opioids on central thermoregulatory mechanisms. Pharmacol. Biochem & Behav. 10, 609–613.

    Article  CAS  Google Scholar 

  14. Holaday, J.W. and Loh, H.H. 1981. Neurobiology of beta-endorphin and related peptides. In Li, C.H.(ed.): Hormonal Proteins and Peptides: Beta-endorphin. New York: Academic Press, 204–291.

    Google Scholar 

  15. Deeter, W.T. and Mueller, G.P. 1981. Differential effects of warm and cold ambient temperature on blood levels of beta-endorphin and prolactin in the rat. Proc. Soc. Exp. Biol. Med. 168, 369–372.

    PubMed  CAS  Google Scholar 

  16. Holaday, J.W., Wei, E.T., Loh, H.H. and Li, C.H. 1978. Endorphins may function in heat adaptation. Proc. Natl. Acad. Sci. 75, 2923–2927.

    Article  PubMed  CAS  Google Scholar 

  17. Holaday, J.W. and Faden, A.I. 1980. Naloxone acts at central opiate receptors to reverse hypotension, hypothermia, and hypoventilation in spinal shock. Brain Res. 189, 295–299.

    Article  PubMed  CAS  Google Scholar 

  18. Florez, J. and Mediavilla, A, 1977. Respiratory and cardiovascular effects of met-enkephalin applied to the ventral surface of the brain stem. Brain Res. 183, 585–590.

    Article  Google Scholar 

  19. Sapru, H.N. and Krieger, A.J. 1979. Cardiovascular and respiratory effects of (D-Met -Pro -enkephalinamide in the decerebrate rat. Fed. Proc. 38, 681.

    Google Scholar 

  20. Moss, I.R. and Friedman, E. 1978. Beta-endorphin effects on respiratory regulation. Life Sci. 23, 1271–1276.

    Article  PubMed  CAS  Google Scholar 

  21. Sapru, H.N., Willette, R.N. and Krieger, A.J. 1981. Stimulation of pulmonary J receptors by an enkephalin analog. J. Pharmacol. Exp. Ther. 217, 228–234.

    PubMed  CAS  Google Scholar 

  22. Holaday, J.W. 1983. Cardiovascular effects of endogenous opiate systems. Ann Rev. Pharmacol. Toxicol. 23, 541–594.

    Article  CAS  Google Scholar 

  23. Ward, S.J. and Holaday, J.W. 1982. Relative involvement of mu and delta opioid mechanisms in morphine-induced depression of respiration in rats. Soc. Neurosci. Abstr. 8, 388.

    Google Scholar 

  24. Lawson, E.E., Waldrop, T.G. and Eldridge, F.L. 1979. Naloxone enhances respiratory output in cats. J. App. Physiol.: Respir. Environ. Exercise Physiol. 47, 1105–1111.

    CAS  Google Scholar 

  25. Isom, G.E. and Elshowihy, R.M. 1982. Naloxone-induced enhancement of carbon dioxide stimulated respiration.

    Google Scholar 

  26. Chernick, V., Madansky, D.L. and Lawson, E.E. 1980. Naloxone decreases the duration of primary apnea with neonatal asphyxia. Pediatr. Res. 14, 357–359.

    Article  PubMed  CAS  Google Scholar 

  27. Moss, I.R. and Scarpelli, E.M. 1979. Generation and regulation of breathing in utero: fetal C02 response test. J. App. Physiol 47, 527–531.

    CAS  Google Scholar 

  28. Malcolm, D.S. and Holaday, J.W. Opioid peptides and their antagonists: a role in respiratory function. Seminars in Respir. Med. In press.

    Google Scholar 

  29. Kiang, J.G. and Wei, E.T. 1984. Peripheral opioid receptors influencing heart rate in rats: evidence for endogenous tolerance. Reg. Peptides 8, 297–303.

    Article  CAS  Google Scholar 

  30. Lemaire, I., Tseng, R. and Lemaire, S. 1978. Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway. Proc. Natl. Acad. Sci. 75, 6240–6242.

    Article  PubMed  CAS  Google Scholar 

  31. Sander, G., Giles, T., Kastin, A., et al. Leucine-enkephalin: reversal of intrinsic cardiovascular stimulation by pentobarbital. Eur. J. Pharmacol. In press.

    Google Scholar 

  32. Feldberg, W. and Wei. E. 1978. Central cardiovascular effects of enkephalins and c-fragment of lipotropin. J. Physio. 280, 18P.

    CAS  Google Scholar 

  33. Harder, D.R. and Madden, J.A. 1984. Cellular mechanisms of opiate receptor stimulation in cat middle cerebral artery. Eur. J. Pharmacol. 102, 411–416.

    Article  PubMed  CAS  Google Scholar 

  34. Holaday, J.W. and Faden, A.I. 1978. Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature 275, 450–451.

    Article  PubMed  CAS  Google Scholar 

  35. Faden, A.I. and Holaday, J.W. 1980. Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat. J. Pharmacol. Exp. Ther. 212, 441–447.

    PubMed  CAS  Google Scholar 

  36. Reynolds, D.G., Gurll, N.J., Vargish, T., et al, 1980. Blockade of opiate receptors with naloxone improves survival and cardiac performance in canine endotoxic shock. Circ. Shock 7, 39–48.

    PubMed  CAS  Google Scholar 

  37. Holaday, J.W., D’Amato, R.J., Ruvio, B.A., et al. 1983. Adrenalectomy blocks pressor responses to naloxone in endotoxic shock: evidence for sympatho-medullary involvement. Cir. Shock 11, 201–210.

    CAS  Google Scholar 

  38. Holaday, J.W., Pasternak, G.W. D’Amato, R.J., Ruvio, B.A. and Faden, A.I. 1983. Naloxazone lacks therapeutic effects in endotoxic shock yet blocks the effects of naloxone. Eur. J. Pharmacol. 89, 293–296.

    Article  PubMed  CAS  Google Scholar 

  39. D’Amato, R.J. and Holaday, J.W. 1984. Multiple opiate receptors in endotoxic shock: evidence for delta involvement and mu-delta interactions in vivo. Proc. Nat’l Acad. Sci. 81, 2898–2901.

    Article  Google Scholar 

  40. Long, J.B., Ruvio, B.A., Glatt, C.E. and Holaday, J.W. ICI 174864, a putative delta opioid antagonist, reverses endotoxemic hypotension: pretreatment with dynorphin 1–13, a K agonist, blocks this action. Neuropeptides. In press.

    Google Scholar 

  41. Koyama, S., Santiesteban, H.L., Ammons, W.S. and Manning, J.W. 1983. The effects of naloxone on the peripheral sympathetics in cat endotoxin shock. Circ. Shock 10, 7–13.

    PubMed  CAS  Google Scholar 

  42. Long, J.B., Lake, C.R., Reid, A., et al. 1983. Effects of naloxone and TRH on plasma catecholamines and arterial pressure in normal and endotoxemic rats. Soc. Neurosci. Abstr. 9, 107.

    Google Scholar 

  43. Paciorek, P.M. and Todd, M.H. 1982. Comparison of the cardiovascular effects of meptazinol and naloxone following anaphylactic shock in anesthetized rats. Br. J. Pharmacol. 75, 128P.

    Google Scholar 

  44. Amir S. 1982. Opiate antagonists improve survival in anaphylactic shock. Eur. J. Pharmacol. 80, 161–162.

    Article  PubMed  CAS  Google Scholar 

  45. Amir. S. 1983. Antianaphylactic effect of naloxone in mice is mediated by increased central sympathetic outflow to sympathetic nerve endings and adrenal medulla. Brain Res. 274, 180–183.

    Article  PubMed  CAS  Google Scholar 

  46. Lux, W.E., Feuerstein, G. and Faden, A.I. 1983. Alteration of leukotriene D4 hypotension by thyrotropin releasing hormone. Nature 302, 822–824.

    Article  PubMed  CAS  Google Scholar 

  47. Faden, A.I. and Holaday, J.W. 1979. Opiate antagonists: a role in the treatment of hypovolemic shock. Science 205, 317–318.

    Article  PubMed  CAS  Google Scholar 

  48. Vargish, T., Reynolds, D.G., Gurll, N.J., et al. 1980. Naloxone reversal of hypovolemic shock in dogs. Circ. Shock 7, 31–38.

    Google Scholar 

  49. Curtis, M.T. and Lefer, A.M. 1982. Beneficial action of a new opiate antagonist (WIN 44, 441–3) in hemorrhagic shock. Eur. J. Pharmacol. 78, 307–313.

    Article  PubMed  CAS  Google Scholar 

  50. Feuerstein, G., Faden, A.I. and Krumins, S.A. 1984. Alteration in opiate receptors binding after hemorrhagic shock. Eur. J. Pharmacol. 100, 245–246.

    Article  PubMed  CAS  Google Scholar 

  51. Lechner, R.B., Gurll, N.J. and Reynolds, D.G. Intracoronary naloxone in hemorrhagic shock: dose-dependent, stereospecific effects. Am. J. Physiol. In press.

    Google Scholar 

  52. Holaday, J.W. and Faden, A.I. 1980. Naloxone acts at central opiate receptors to reverse hypotension, hypothermia and hypoventilation in spinal shock. Brain Res. 189, 295–299.

    Article  PubMed  CAS  Google Scholar 

  53. Faden, A.I., Jacobs, T.P. and Holaday, J.W. 1980. Endorphin-parasympathetic interaction in spinal shock. J. Autonomic Nerv. System 2, 295–304.

    Article  CAS  Google Scholar 

  54. Tiengo, M. 1980. Naloxone in irreversible shock. Lancet, i, 690.

    Google Scholar 

  55. Peters, W.P., Johnson, M.W., Friedman, P.A. and Mitch, W.E. 1981. Pressor effect of naloxone in septic shock. Lancet i, 529–532.

    Google Scholar 

  56. Gurll, N.J. 1983. Naloxone in endotoxic shock: experimental models and clinical perspective. In Reichard, S. and Reynolds, D. (eds.): Advances in Shock Research, Vol. 10. New York: Alan R. Liss, 63–72.

    Google Scholar 

  57. Belenky, G.L. and Holaday, J.W. 1979. The opiate antagonist naloxone modifies the effects of electroconvulsive shock ( ECS) on blood pressure, heart rate and respiration. Brain Res. 177, 414–417.

    Article  PubMed  CAS  Google Scholar 

  58. Dworkin, B.R., Filewich, R.J., Miller, N.E., et al. 1979. Baroreceptor activation reduces reactivity to noxious stimulation: implications for hypertension. Science 205, 1299–1301.

    Article  PubMed  CAS  Google Scholar 

  59. Zamir, N. and Segal, M. 1979. Hypertension-induced analgesia: changes in pain sensitivity in experimental hypertensive rats. Brain Res. 160, 170–173.

    Article  PubMed  CAS  Google Scholar 

  60. Quock, R.M., Vaughn, L.K. and Kouchich, F.J. 1984. Influence of chronic naloxone treatment on development of hypertension in the spontaneously hypertensive rat. Naunyn-Schmied. Arch, Pharmacol. 325, 88–90.

    Article  CAS  Google Scholar 

  61. Farsang, C and Kunos, G. 1979. Naloxone reverses the antihypertensive effects of clonidine. Br. J. Pharmacol. 67, 247–250.

    Google Scholar 

  62. Paterson, S.J., Robson, L.E. and Kosterlitz, H.W. 1983. Classification of opioid receptors. Br. Med. Bull 39, 31–36.

    PubMed  CAS  Google Scholar 

  63. Schulz, R., Wuster, M. and Herz, A. 1981 Pharmacological characterization of the E-Opiate receptor. J. Pharmacol. Exp. Ther. 216, 604–606.

    PubMed  CAS  Google Scholar 

  64. Schulz, R., Wuster, M., Kreuss, H., and Herz, A. 1980. Selective development of tolerance without dependence in multiple opiate receptors of mouse vas deferens. Nature 285, 242–243.

    Article  PubMed  CAS  Google Scholar 

  65. Vonvoigtlander, P.F., Lahti, R.A. and Ludeus, J.H. 1983. U-50,488: a selective and structurally novel non-mu (kappa) opioid agonist. Pharmacol. Exp. Ther. 224, 7.

    CAS  Google Scholar 

  66. Goldstein, A., James, I.F. Site-directed alkylation of multiple opioid receptors: II. pharmacologic selectivity. Molecular Pharm. In press.

    Google Scholar 

  67. Robson, L.E., Kosterlitz, H.W. U979. Specific protection of the binding sites of D-Ala2-D-Leu2-enkephalin (delta receptors) and dihydromorphine (mu-receptors). Proc. R. Soc. London, B 205, 425–432.

    Article  CAS  Google Scholar 

  68. Bowen, W.D., Gentleman, S., Herkenhan, M. and Pert, C. 1981. Interconverting mu and delta forms of the opiate receptor in rat striatal patches. Proc. Nat’l Acad. Sci. 78, 4818–4822.

    Article  CAS  Google Scholar 

  69. Lee, N.M., Smith, A.P. 1980. A protein-lipid model of the opiate receptor. Life Sci. 26, 1459–1464.

    Article  PubMed  CAS  Google Scholar 

  70. Rothman, R.B., and Westfall, T.C. 1982. Allosteric coupling between morphine and enkephalin receptors in vitro. Molecular Pharm. 21, 548–557.

    CAS  Google Scholar 

  71. Vaught, J.L., Rothman, R.B., and Westfall, R.C. 1982. Mu and delta receptors: their role in analgesia and in the differential effects of opioid peptides on analgesia. Life Sci. 30, 1443–1455.

    Article  PubMed  CAS  Google Scholar 

  72. Tortella, F.C. and Holaday, J.W. 1984. Mu and delta opioid receptor interactions in a rat model of drug induced seizures. Proc. West. Pharmacol. Soc. 27, 435–437.

    PubMed  CAS  Google Scholar 

  73. Gillan, M.G.C., Kosterlitz, H.W., and Magnan, J. 1981. Unexpected antagonism in the rat vas deferens by benzo-morphans which are agonists in other pharmacological tests. Br. J. Pharmacol. 72, 13–15.

    PubMed  CAS  Google Scholar 

  74. Ward, S.J., Portoghese, P.S., and Takemori, A.E. 1982. Pharmacological characterization in vivo of the novel opiate, p-funaltrexamine. J. Pharmacol. Exp. Ther. 220, 494.

    PubMed  CAS  Google Scholar 

  75. Garzon, J., Jen, M.F., Sanchez-Blazquez, P., and Lee, N.M. 1982. Dynorphin (1–13), A long-lasting inhibitor of opiate receptor binding in vitro. Life Sci. 31, 1789.

    Article  PubMed  CAS  Google Scholar 

  76. Cowan, A., Geller, E.B., and Adler, M.W. 1979. Classification of opioids on the basis of change in seizure threshold in rat. Science 206, 456–467.

    Article  Google Scholar 

  77. Tortella, F.C, Robles, L.E., Holaday, J.W. and Cowan, A. 1983. A selective role for mu-receptors in the regulation of opioid-induced changes in seizure threshold. Life Sci. 33, 603–606.

    Article  PubMed  CAS  Google Scholar 

  78. Tortella, F.C. and Holaday, J.W. 1984. Mu and delta opioid receptor interactions in a rat model of drug induced seizures. Proc. West. Pharmacol. Soc. 27, 435–437.

    PubMed  CAS  Google Scholar 

  79. Holaday, J.W., Tseng, L.F., Loh, H.H. and Li, C.H. 1978. Thyrotropin releasing hormone antagonizes p-endorphin hypothermia and catalepsy. Life Sci. 23, 151–158.

    Article  PubMed  Google Scholar 

  80. Holaday, J.W., D’Amato, R.J. and Faden, A.I. 1981. Thyrotropin releasing hormone improves cardiovascular function in experimental endotoxic and hemorrhagic shock. Science 213, 216–218.

    Article  PubMed  CAS  Google Scholar 

  81. Holaday, J.W. and Bernton, E.W. 1984. Thyrotropin releasing hormone: a potent neuromodulator with therapeutic potential. Arch. Int. Med. 144, 1138–1140.

    Article  CAS  Google Scholar 

  82. Holaday, J.W. and Faden, A.I. 1983. TRH: Autonomic effects upon cardiorespiratory function in endotoxic shock. Reg. Peptides 7, 111–125.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Matinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Holaday, J.W. (1986). Opioids and Other Neuropeptides: Functional Interactions with Autonomic Systems. In: Frederickson, R.C.A., Hendrie, H.C., Hingtgen, J.N., Aprison, M.H. (eds) Neuroregulation of Autonomic, Endocrine and Immune Systems. Topics in the Neurosciences, vol 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2315-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2315-0_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9424-5

  • Online ISBN: 978-1-4613-2315-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics